Search All News
Coronavirus Updates from Columbia Psychiatry
“Uncertainty and unreliability — not having the security of knowing what happens yet — has been traumatizing at a core level, from the very beginning,” said Dr. Maureen O’Reilly-Landy.
"I never imagined that I would be attempting to calm my patients’ fears in the midst of a global pandemic during my first two years as a faculty psychologist," writes Dr. Courtney DeAngelis.
Source:Psychiatric TimesDecember 2, 2020
Dr. Joshua Kantrowitz discusses a recent trial of CVN058, a drug that may reduce cognitive impairments in individuals with schizophrenia.
Source:Hello GigglesDecember 2, 2020
“Many people have preconceived notions about antidepressants some of which are based on the unfortunate stigma with mental health,” says Dr. Diana Samuel.
Source:HealthlineDecember 1, 2020
“I honestly find that most Americans do not think that cannabis can produce dependence, and so I think that’s the first step, knowing that there’s that potential,” says Margaret Haney, PhD
- December 1, 2020
The American College of Neuropsychopharmacology (ACNP) has named Columbia Psychiatry’s Helen Blair Simpson, M.D., Ph.D., as the recipient of the 2020 Julius Axelrod Mentorship Award.
- November 30, 2020
"Our guidance emphasizes the importance of building resilience in families. We should instead focus on “what’s strong” and consistently build those factors," said Dr. Evelyn Berger-Jenkins.
Source:Rolling StoneNovember 24, 2020
Bulimia nervosa is an eating disorder characterized by episodes of binge eating followed by compensatory behaviors aimed at preventing weight gain, most commonly vomiting, explains Dr. Evelyn Attia.
- November 16, 2020
The Substance Abuse and Mental Health Services Administration has awarded $32 million to the American Academy of Addiction Psychiatry to address opioid use disorders and stimulant use disorders.